These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2134672)
1. Altered expression of cytochrome P-450 isozymes by aromatic amine carcinogens in experimental animals: correlation with hepatocarcinogenesis. Hashimoto Y; Miura S; Degawa M Princess Takamatsu Symp; 1990; 21():129-36. PubMed ID: 2134672 [TBL] [Abstract][Full Text] [Related]
2. Expression and induction of cytochrome P450 isozymes in hyperplastic nodules of rat liver. Degawa M; Miura S; Hashimoto Y Carcinogenesis; 1991 Nov; 12(11):2151-6. PubMed ID: 1934303 [TBL] [Abstract][Full Text] [Related]
3. Hepatocarcinogenic heterocyclic aromatic amines that induce cytochrome P-448 isozymes, mainly cytochrome P-448H (P-450IA2), responsible for mutagenic activation of the carcinogens in rat liver. Degawa M; Tanimura S; Agatsuma T; Hashimoto Y Carcinogenesis; 1989 Jun; 10(6):1119-22. PubMed ID: 2720904 [TBL] [Abstract][Full Text] [Related]
4. [Chemical carcinogenesis and cytochrome P450: carcinogenic aromatic amine-induced P450 and hepatocarcinogenic susceptibility to the aromatic amine in the rodent]. Degawa M Yakugaku Zasshi; 1995 Jan; 115(1):1-14. PubMed ID: 7699577 [TBL] [Abstract][Full Text] [Related]
5. Species difference among experimental rodents in the activity and induction of cytochrome P-450 isozymes for mutagenic activation of carcinogenic aromatic amines. Degawa M; Agatsuma T; Hashimoto Y Jpn J Cancer Res; 1990 Dec; 81(12):1253-8. PubMed ID: 2125995 [TBL] [Abstract][Full Text] [Related]
6. Development of cytochrome P-450-altered preneoplastic and neoplastic lesions during nitrosamine-induced hepatocarcinogenesis in the rat. Buchmann A; Schwarz M; Schmitt R; Wolf CR; Oesch F; Kunz W Cancer Res; 1987 Jun; 47(11):2911-8. PubMed ID: 3567909 [TBL] [Abstract][Full Text] [Related]
7. Induction of cytochrome P450 isoforms by carcinogenic aromatic amines and carcinogenic susceptibility of rodent animals. Hashimoto Y; Degawa M Pharmacogenetics; 1995; 5 Spec No():S80-3. PubMed ID: 7581495 [TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of aromatic amine carcinogens in vitro and in vivo. Beland FA J UOEH; 1989 Mar; 11 Suppl():387-97. PubMed ID: 2664951 [No Abstract] [Full Text] [Related]
9. Species difference among experimental rodents in induction of P450IA family enzymes by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Degawa M; Kobayashi K; Miura S; Arai H; Esumi H; Sugimura T; Hashimoto Y Jpn J Cancer Res; 1992 Oct; 83(10):1047-51. PubMed ID: 1452456 [TBL] [Abstract][Full Text] [Related]
10. Species, sex and organ differences in induction of a cytochrome P-450 isozyme responsible for carcinogen activation: effects of dietary hepatocarcinogenic tryptophan pyrolysate components in mice and rats. Degawa M; Hishinuma T; Yoshida H; Hashimoto Y Carcinogenesis; 1987 Dec; 8(12):1913-8. PubMed ID: 3677314 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of 3-methylcholanthrene induction of rat hepatic cytochrome P450IA1 by dexamethasone in vivo. Sherratt AJ; Banet DE; Linder MW; Prough RA J Pharmacol Exp Ther; 1989 May; 249(2):667-72. PubMed ID: 2566684 [TBL] [Abstract][Full Text] [Related]
12. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention. Buetler TM; Bammler TK; Hayes JD; Eaton DL Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305 [TBL] [Abstract][Full Text] [Related]
13. Hepatic cytochrome P-450 isozyme(s) induced by dietary carcinogenic aromatic amines preferentially in female mice of DBA/2 and other strains. Degawa M; Yamaya C; Hashimoto Y Carcinogenesis; 1988 Apr; 9(4):567-71. PubMed ID: 3356064 [TBL] [Abstract][Full Text] [Related]
14. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Webb SJ; Xiao GH; Geoghegan TE; Prough RA Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760 [TBL] [Abstract][Full Text] [Related]
15. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines. Poupko JM; Radomski T; Santella RM; Radomski JL J Natl Cancer Inst; 1983 Jun; 70(6):1077-80. PubMed ID: 6574277 [TBL] [Abstract][Full Text] [Related]
16. Induction of cytochrome P4501A isozymes by heterocyclic amines and other food-derived compounds. Kleman MI; Overvik E; Poellinger L; Gustafsson JA Princess Takamatsu Symp; 1995; 23():163-71. PubMed ID: 8844807 [TBL] [Abstract][Full Text] [Related]
17. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital. Robertson IG; Serabjit-Singh C; Croft JE; Philpot RM Mol Pharmacol; 1983 Jul; 24(1):156-62. PubMed ID: 6865923 [TBL] [Abstract][Full Text] [Related]
18. Microsomal N- and C-oxidations of carcinogenic aromatic amines and amides. Lotlikar PD; Hong YS Natl Cancer Inst Monogr; 1981 Dec; (58):101-7. PubMed ID: 7341966 [TBL] [Abstract][Full Text] [Related]
19. Induction of mouse cytochrome P450 2B enzymes by amine metabolites of musk xylene: contribution of microsomal enzyme induction to the hepatocarcinogenicity of musk xylene. Lehman-McKeeman LD; Stuard SB; Caudill D; Johnson DR Mol Carcinog; 1997 Nov; 20(3):308-16. PubMed ID: 9397191 [TBL] [Abstract][Full Text] [Related]
20. Induction of putative new cytochrome P450 isozyme in rat liver by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Adachi H; Degawa M; Miura S; Hashimoto Y; Sugimura T; Esumi H Biochem Biophys Res Commun; 1991 Jan; 174(2):797-803. PubMed ID: 1993073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]